Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Evaluation of a Apo-1/Fas promoter polymorphism in Korean stroke patients.

Experimental & molecular medicine - 30 Sept 2002

Seo Jung-Chul, Han Sang-Won, Yin Chang-Sik, Koh Hyung-Kyun, Kim Chang-Hwan, Kim Ee-Hwa, Leem Kang-Hyun, Lee Hyang-Sook, Park Hi-Joon, Kim Soon-Ae, Choe Bong-Keun, Lee Hee-Jae, Yim Sung-Vin, Kim Chang-Ju, Chung Joo-Ho

Abstract excerpt

Apoptosis has been implicated in the pathogenesis of neurodegenerative diseases such as stroke and Alzheimer's disease. Apo-1/Fas gene is one of the mediators of apoptosis in stroke. Mval polymorphism is the first polymorphic marker identified in the Apo-1/Fas gene promoter, which was typed by PCR and followed by Mval digestion and gel electrophoresis. DNA isolated from peripheral blood collected from 91 stroke...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Aged
Share to Cerebral Infarction

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Share to fas Receptor

Share to Gene Frequency

Share to Genotype

Share to Polymorphism, Genetic

Share to Promoter Regions, Genetic

Source

Identifiers

PMID: 12515395
DOI: 10.1038/emm.2002.41

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 7 Sept 2026. Manifest publication-graph-cohort-2026-09-07.1.

Source receipt: pubmed, retrieved 7 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Evaluation of a Apo-1/Fas promoter polymorphism in Korean stroke patients.PMID 12515395Read ↗

Identification and characterization of polymorphisms in the promoter region of the human Apo-1/Fas (CD95) gene.Semantic proximity Read ↗

An examination of the Apo-1/Fas promoter Mva I polymorphism in Japanese patients with multiple sclerosis.Semantic proximity Read ↗

Investigation of the -1377 polymorphism on the Apo-1/Fas promoter in systemic lupus erythematosus patients using allele-specific amplification.Semantic proximity Read ↗

A functional polymorphism in fas (CD95/APO-1) gene promoter associated with systemic lupus erythematosus.Semantic proximity Read ↗

Evaluation of apoptosis-related gene Fas (CD95) and FasL (CD178) polymorphisms in Iranian rheumatoid arthritis patients.Semantic proximity Read ↗

Evaluation of apoptosis-related genes: Fas (CD94), FasL (CD178) and TRAIL polymorphisms in Iranian multiple sclerosis patients.Semantic proximity Read ↗

Fas promoter region gene polymorphism is associated with an increased risk for myocardial infarction.Semantic proximity Read ↗

Evaluation of the apo-1/Fas promoter mva I polymorphism in multiple sclerosis.Semantic proximity Read ↗

Evaluation of Fas gene promoter polymorphism in cervical cancer patients.Semantic proximity Read ↗

Susceptibility for ischemic stroke in Korean population is associated with polymorphisms of the interleukin-1 receptor antagonist and tumor necrosis factor-alpha genes, but not the interleukin-1beta gene.Semantic proximity Read ↗

Identification and functional characterization of a highly polymorphic region in the human TRAIL promoter in multiple sclerosis.Semantic proximity Read ↗

Genetic determinants of neuronal vulnerability to apoptosis.Semantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.